Home › Heart Attack › Kentucky
Heart Attack clinical trials in Kentucky
3 studies for Heart Attack are looking for participants at sites in Kentucky.
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Nephrology Associates of Kentuckiana, PSC, Louisville
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Graves Gilbert Clinic, Bowling Green
- Baptist Health Lexington, Lexington
- The Research Group of Lexington LLC, Lexington
RecruitingPhase 3
Ages 50 to 105 · All sexes · Updated Aug 21, 2026 · NCT07136012Focused Orticumab Research for Treating Inflammation in Coronary Arteries
- Abcentra Investigational Site, Louisville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jan 27, 2026 · NCT06927739From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.